Publications and Presentations Database

Sort by: Author [ Title (Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Baptista, N. M., Christensen, K. D., Carere, D. A., Broadley, S. A., Roberts, J. S., & Green, R. C. (2016).  Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees.. Genetics in medicine : official journal of the American College of Medical Genetics. 18(9), 924-32. Abstract
Roberts, J. S., Blow, F. C., Copeland, L. A., Barry, K. L., & Van Stone, W. (2000).  Age-group differences in treatment outcomes for male veterans with severe schizophrenia: a three-year longitudinal study. Journal of geriatric psychiatry and neurology. 13(2), 78-86. Abstract
Roberts, J. S., Dunn, L. B., & Rabinovici, G. D. (2013).  Amyloid imaging, risk disclosure and Alzheimer’s disease: ethical and practical issues. Neurodegenerative disease management. 3(3), 219 - 229.
Roberts, J. S. (2000).  Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives. The gerontologist. 40(1), 43-52. Abstract
Qian, J., Wolters, F. J., Beiser, A., Haan, M., Ikram, A. M., Karlawish, J., et al. (2017).  APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.. PLoS medicine. 14(3), e1002254. Abstract
Shiloh, S., Wade, C. H., Roberts, J. S., Alford, S. H., & Biesecker, B. B. (2013).  Associations between risk perceptions and worry about common diseases: a between- and within-subjects examination. Psychology & Health. 28(4), 434-49. Abstract
Christensen, K. D., Roberts, J. S., Zikmund-Fisher, B. J., Kardia, S. L. R., McBride, C. M., Linnenbringer, E., et al. (2015).  Associations between self-referral and health behavior responses to genetic risk information.. Genome medicine. 7(1), 10. Abstract
B
Connell, C. M., Roberts, J. S., McLaughlin, S. J., & Carpenter, B. D. (2009).  Black and white adult family members' attitudes toward a dementia diagnosis. Journal of the American geriatrics society. 57(9), 1562-8. Abstract
C
Christensen, K. D., Roberts, J. S., Uhlmann, W. R., & Green, R. C. (2011).  Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk. Genetics in medicine : official journal of the American College of Medical Genetics. Abstract
Green, R. C., Goddard, K. A. B., Jarvik, G. P., Amendola, L. M., Appelbaum, P. S., Berg, J. S., et al. (2016).  Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.. American journal of human genetics. 99(1), 246.
Grill, J. D., Apostolova, L. G., Bullain, S., Burns, J. M., Cox, C. G., Dick, M., et al. (2017).  Communicating mild cognitive impairment diagnoses with and without amyloid imaging.. Alzheimer's research & therapy. 9(1), 35. Abstract
Cassidy, M. R., Roberts, J. S., Bird, T. D., Steinbart, E. J., Cupples, A. L., Chen, C. A., et al. (2008).  Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease. Alzheimer's & Dementia : the journal of the Alzheimer's Association. 4(6), 406-13. Abstract
van der Wouden, C. H., Carere, D. A., Maitland-van der Zee, A. H., Ruffin, M. T., Roberts, J. S., & Green, R. C. (2016).  Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing.. Annals of internal medicine. 164(8), 513-22. Abstract
Roberts, J. S. (2014).  Current research trends in Alzheimer’s disease.
D
Carere, D. A., Couper, M. P., Crawford, S. D., Kalia, S. S., Duggan, J. R., Moreno, T. A., et al. (2014).  Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers.. Genome medicine. 6(12), 96. Abstract
Lingler, J. H., Butters, M. A., Gentry, A. L., Hu, L., Hunsaker, A. E., Klunk, W. E., et al. (2016).  Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment.. Journal of Alzheimer's disease : JAD. 52(1), 17-24. Abstract
Nielsen, D. E., Carere, D. A., Wang, C., Roberts, J. S., & Green, R. C. (2017).  Diet and exercise changes following direct-to-consumer personal genomic testing.. BMC medical genomics. 10(1), 24. Abstract
Hipps, Y. G., Roberts, J. S., Farrer, L. A., & Green, R. C. (2003).  Differences between African Americans and Whites in their attitudes toward genetic testing for Alzheimer's disease. Genetic testing. 7(1), 39-44. Abstract
Roberts, J. S., Connell, C. M., Cisewski, D., Hipps, Y. G., Demissie, S., & Green, R. C. (2003).  Differences between African Americans and whites in their perceptions of Alzheimer disease. Alzheimer disease and associated disorders. 17(1), 19-26. Abstract
Roberts, J. S., & Ostergren, J. (2013).  Direct-to-consumer genetic testing and personal genomics services: a review of recent empirical studies. Current genetic medicine reports. 1(3), 182-200. Abstract
Roberts, J. S., Gornick, M. C., Carere, D. A., Uhlmann, W. R., Ruffin, M. T., & Green, R. C. (2017).  Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results.. Public health genomics. 20(1), 36-45. Abstract
Christensen, K. D., Roberts, J. S., Shalowitz, D. I., Everett, J. N., Kim, S. Y. H., Raskin, L., et al. (2011).  Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
Christensen, K. D., Roberts, J. S., Whitehouse, P. J., Royal, C. D. M., Obisesan, T. O., Cupples, A. L., et al. (2016).  Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial.. Annals of internal medicine. 164(3), 155-63. Abstract
Ashida, S., Koehly, L. M., Roberts, J. S., Chen, C. A., Hiraki, S., & Green, R. C. (2009).  Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease. Journal of health communication. 14(8), 768-84. Abstract
Green, R. C., Roberts, J. S., Cupples, A. L., Relkin, N. R., Whitehouse, P. J., Brown, T., et al. (2009).  Disclosure of APOE genotype for risk of Alzheimer's disease. The New England journal of medicine. 361(3), 245-54. Abstract